Retrospective Analysis of the Safety of Herceptin® Immunotherapy in Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|61|2|58-66

ISSN： 0030-2414

Source： Oncology, Vol.61, Iss.2, 2001-10, pp. : 58-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

First-Line Herceptin® Monotherapy in Metastatic Breast Cancer

By  

Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. : 37-42

Karger

Access to resources Recommend Favorite

New Combinations with Herceptin® in Metastatic Breast Cancer

By  

Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. : 50-57

Karger

Access to resources Recommend Favorite

A Retrospective Analysis of the Activity and Safety of Oral Etoposide in Heavily Pretreated Metastatic Breast Cancer Patients

By  

THE BREAST JOURNAL, Vol. 21, Iss. 3, 2015-05 ,pp. : 241-245

John Wiley & Sons Inc

Access to resources Recommend Favorite

What Can We Learn from Herceptin® Trials in Metastatic Breast Cancer?

By  

Oncology, Vol. 63, Iss. 1, 2002-11 ,pp. : 39-46

Karger

Access to resources Recommend Favorite

Efficacy and Safety of S-1 in Patients with Metastatic Breast Cancer: Retrospective Review in a Single Institution

By  

Oncology, Vol. 79, Iss. 3-4, 2011-03 ,pp. : 273-277

Karger

Access to resources Recommend Favorite